相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The therapeutic potential of polymersomes loaded with 225AC evaluated in 2D and 3D in vitro glioma models
R. M. de Kruijff et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Liposomes and polymersomes: a comparative review towards cell mimicking
Emeline Rideau et al.
CHEMICAL SOCIETY REVIEWS (2018)
Tumor accumulation of liposomal doxorubicin in three murine models: Optimizing delivery efficiency
Charlene M. Dawidczyk et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Improved 225AC daughter retention in InPO4 containing polymersomes
R. M. de Kruijff et al.
APPLIED RADIATION AND ISOTOPES (2017)
Tumor Presence Induces Global Immune Changes and Enhances Nanoparticle Clearance
Marc P. Kai et al.
ACS NANO (2016)
Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts
Michiel Bolkestein et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Pharmacokinetics of Polymersomes Composed of Poly(Butadiene-Ethylene Oxide); Healthy versus Tumor-Bearing Mice
G. Wang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
Accumulating nanoparticles by EPR: A route of no return
Romeo Ngoune et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Mechanism of hard-nanomaterial clearance by the liver
Kim M. Tsoi et al.
NATURE MATERIALS (2016)
Nanoparticles in the clinic
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2016)
111In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages
Samantha Y. A. Terry et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect
Andrew D. Wong et al.
PLOS ONE (2015)
Retention studies of recoiling daughter nuclides of 225AC in polymer vesicles
G. Wang et al.
APPLIED RADIATION AND ISOTOPES (2014)
Macrophage heterogeneity in tissues: phenotypic diversity and functions
Siamon Gordon et al.
IMMUNOLOGICAL REVIEWS (2014)
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background
Stephen W. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Polymersomes as radionuclide carriers loaded via active ion transport through the hydrophobic bilayer
G. Wang et al.
SOFT MATTER (2013)
Nanoparticles in cancer therapy and diagnosis
Irene Brigger et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Size Dependent Biodistribution and SPECT Imaging of 111In-Labeled Polymersomes
Rene P. Brinkhuis et al.
BIOCONJUGATE CHEMISTRY (2012)
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Nicolas Bertrand et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Zhiliang Cheng et al.
SCIENCE (2012)
Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects
Jin-Wook Yoo et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo
Rupa R. Sawant et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Pharmacokinetics and biodistribution of nanoparticles
Shyh-Dar Li et al.
MOLECULAR PHARMACEUTICS (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Nanoparticles in medicine: Therapeutic applications and developments
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Targeted nanoparticle-based drug delivery and diagnosis
Dwaine F. Emerich et al.
JOURNAL OF DRUG TARGETING (2007)
Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug
Fariyal Ahmed et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Clodronate-liposome-mediated depletion of tumour-associated macrophages:: a new and highly effective antiangiogenic therapy approach
S. M. Zeisberger et al.
BRITISH JOURNAL OF CANCER (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Poly(ethylene oxide)-modified poly(ε-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer
DB Shenoy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
A pegylated liposomal platform: Pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug
WL Lu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer
GJR Charrois et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses
P Aichele et al.
JOURNAL OF IMMUNOLOGY (2003)
Polymer vesicles in vivo: correlations with PEG molecular weight
PJ Photos et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles
K Avgoustakis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
